We rank companies based on fund manager, research analyst and news sentiment
XRAY stock icon

Dentsply Sirona
XRAY

$30.36
1.4%
 

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 15,000

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 12 analysts
0
News positive %
of 8 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

9% more capital invested

Capital invested by funds: $6.92B [Q3] → $7.55B (+$624M) [Q4]

5.02% more ownership

Funds ownership: 95.07% [Q3] → 100.08% (+5.02%) [Q4]

13% less call options, than puts

Call options by funds: $2.82M | Put options by funds: $3.22M

14% less funds holding

Funds holding: 466 [Q3] → 400 (-66) [Q4]

32% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 176

55% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 119

Research analyst outlook

12 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$32
5%
upside
Avg. target
$39
27%
upside
High target
$43
42%
upside

12 analyst ratings

positive
67%
neutral
33%
negative
0%
Barrington Research
Michael Petusky
35%upside
$41
Outperform
Reiterated
1 Mar 2024
Needham
David Saxon
38%upside
$42
Buy
Reiterated
29 Feb 2024
Leerink Partners
Michael Cherny
38%upside
$42
Outperform
Initiated
26 Feb 2024
Piper Sandler
Jason Bednar
15%upside
$35
Neutral
Maintained
12 Jan 2024
Needham
David Saxon
38%upside
$42
Buy
Maintained
9 Jan 2024

Financial journalist opinion

Based on 8 articles about XRAY published over the past 30 days